Covid19SupportGrpSA retweeted
Replying to @1goodtern
Not any better in the USA, as I discovered today:
Covid19SupportGrpSA retweeted
What did I tell you about the sirens.
WEAR A MASK.
Covid19SupportGrpSA retweeted
Replying to @SkyNews
Coincidence there is a massive COVID wave at the moment?
It's almost like denying biological reality is not an effective way to end a pandemic.
Covid19SupportGrpSA retweeted
An experimental leukemia vaccine has successfully passed a pivotal Phase 3 clinical trial.
The treatment, known as galinpepimut-S (GPS), works by training the immune system to identify and destroy residual leukemia cells left behind after initial therapy. Using small protein fragments called peptides, the vaccine directs immune cells toward WT1, a protein commonly expressed on leukemia cells, to help prevent the cancer from returning. Unlike personalized cancer vaccines that must be custom-engineered from an individual patient's tumor, GPS features a standardized, off-the-shelf formulation ready for broad clinical use.
In the randomized Phase 3 REGAL trial (NCT04229979), patients receiving GPS achieved a median overall survival of 24 months, compared with 14.7 months for those given the best available standard treatment. According to initial topline results announced on November 17, 2026, this improvement represents a 41% reduction in the relative risk of death during the follow-up period.
The study enrolled 126 patients with acute myeloid leukemia (AML), an aggressive blood cancer, who had relapsed after prior therapy and subsequently reached a second or later remission. Because these participants were ineligible for or unable to receive a donor stem-cell transplant, they faced very limited treatment alternatives. Importantly, GPS is designed as a therapeutic maintenance vaccine to prevent relapse in existing patients, rather than a preventive shot for healthy individuals.
Researchers reported that treatment-related side effects were predominantly mild to moderate, with localized reactions at the injection site being the most frequent issue. While the full dataset—including deeper survival and relapse analyses—is slated for presentation at an upcoming medical conference and submission to a peer-reviewed journal, the trial's protocol and design were previously published in Future Oncology.
Covid19SupportGrpSA retweeted
I don't think people realise how big a deal this is.
If you have cancer, or somebody you know has cancer, there is a company in Hyderabad that wants to build a personalised cancer vaccine for you.
Try approaching any big pharma company and asking for a personal vaccine. If they even reply to your email, this is the response you'll get: we don't do that here.
PopVax, on the other hand, takes your tumour sequencing data (or a sequence you've designed), designs candidate neoantigen vaccine sequences with their AI pipeline, produces the mRNA, encapsulates it in their LNP formulation, fills vials, and runs QC, all in 8 to 10 weeks. They’re publicly committing to capacity for 100+ of these over the next 12 months and asking people to email them their cancer type/stage and sequencing details.
What a time to be alive.
A 20-year study of a million children found that kids conceived by IVF frozen embryo transfer had double the cancer rate.
84% of US IVF transfers now use frozen embryos.
Danish researchers followed every child born in Denmark from 1996 to 2012 for up to 20 years. The study was published in JAMA last week.
Children conceived without assisted reproduction developed cancer at 18.3 per 100,000 per year.
After frozen embryo transfer, the rate was 41.1.
After ICSI, where a single sperm is injected directly into the egg, it was 27.9.
After frozen transfer, leukemia ran more than twice as high.
The only method that showed no increase was a fresh embryo, never frozen, created by placing eggs and sperm together in a dish.
That version is now the exception. In 2021, 84% of US IVF transfers used frozen embryos and 78% used ICSI, according to the CDC.
Compared with children of women with a history of infertility who conceived without treatment, the frozen embryo risk stayed at more than double.
In the authors' words, the results suggest "procedure-related, rather than infertility-related, factors." This is not the first time the pattern has shown up.
A 2019 JAMA study of the same Danish children at 11 years found it too. A 2022 study of 2.3 million children in Taiwan found those conceived through assisted reproduction had 58% higher cancer risk, "mainly owing to leukemia and hepatic tumor."
The absolute risk is small, and most of these children will never get cancer. The Danish children were conceived with older freezing methods, and the authors warn the results "may differ for contemporary protocols."
Nobody yet has long-term data on IVF as it is done today. Children conceived with today's methods won't have 20 years of data until the 2040s, so today's IVF children are, in effect, the trial.
Parents deserve to hear these numbers before they sign the consent form, because their child is the one who will carry the risk.
doi.org/10.1001/jama.2026.18…
Covid19SupportGrpSA retweeted
The link between obesity and early-onset cancer.
A nationwide study of 6.3 million people, age 20-39, with no prior cancer, by BMI and waist circumference, with 11 year follow-up, in South Korea
acpjournals.org/doi/full/10.… @AnnalsofIM
Covid19SupportGrpSA retweeted
Here’s something you should know about minks:
They have lungs and airways remarkably similar on a cellular level to those of people.
They’ve spread flus and infected humans before with COVID-19.
Right now, bird flu is spreading on a Utah farm filled with thousands of them… 🧵
Covid19SupportGrpSA retweeted
This is playing with fire.
Minks and ferrets have such humanlike lung cells that they’re the standard for testing human flu transmission. (Cows aren’t!)
An H5N1 epidemic raging in a mink farm is basically the plot for Dr. Evil tries to spark a pandemic. Luck isn’t a plan.
Covid19SupportGrpSA retweeted
"Almost every person on Earth carries a variety of different, dormant viruses in their body" NPR in conversation with Akiko Iwasaki @VirusesImmunity
#MECFS & #LongCOVID are characterized by persistent immune response to persistent EBV/HHV/HCoV infections. #AirborneAIDS #WearN95
NPR: 'The dormant viruses in all of us may help explain long COVID'
14-minute listen ft. Akiko Iwasaki.
Host Nathan Rott shares that he has family members impacted by Long COVID
npr.org/2026/10/23/nx-s1-598…
Covid19SupportGrpSA retweeted
Chinese scientists have found that hypoxia and inflammation induced by COVID-19 infection can trigger angiogenesis and accelerate lung tumor growth.
nature.com/articles/s41392-0…
Covid19SupportGrpSA retweeted
"the woman (age: 42 years) who has tested positive for Ebola in Nigeria is the wife of a Swiss diplomat..
the woman had spent about a week at a private clinic in Abuja with symptoms before her diagnosis.
It believes she contracted the virus while travelling in Uganda..
The patient did not travel to DR Congo..
She returned to Nigeria on 3 October after spending about two and a half weeks in Uganda..
She developed symptoms four days after arriving in Abuja and sought treatment at two private health facilities before testing positive for Ebola on 20 October.."
It is improbable that no one contracted the virus over the 17-day period.
'Woman with Ebola in Nigeria confirmed as wife of Swiss diplomat'
bbc.com/news/articles/cmwy4w…
Covid19SupportGrpSA retweeted
Replying to @brownecfm
I go to medical offices when very necessary and always wear an
N95 mask
Saw specialist for injection, (sadly no do it yourself option available)
Nurse asked if I was feeling poorly when she saw my mask.
I said “I’m well and trying to stay that way”
No comment from her
Covid19SupportGrpSA retweeted
Replying to @brownecfm
I had a similar talk yesterday.
I told a friend that he should get vaccinated against the new variant.
He told me he doesn’t plan on getting vaccinated again because he had three vaccinations and was twice infected.
Well, I am more vaccinated and never got COVID-19.
And of course I still do mask in situations with many people or bad ventilation.
We all know what we could do to prevent infections.
When I lecture, I do so on a large room with ventilation (air is sucked to the ceiling) and with HEPA 14 filters. There is a more than 10 times per hour air exchange and about 1 to 3 ppm particles of any size. The risks to get infected at the podium of that room is very low.
So, always know your air quality.
Covid19SupportGrpSA retweeted
Replying to @briankirsty
I firmly believe that we are facing a tsunami of chronic illness, especially dementia, in the coming decade.
Covid19SupportGrpSA retweeted
Replying to @brownecfm
Viruses are yearly. Some years bad, some years not so bad. You never know. This year I got Covid, 3rd time, and it was 21 days of horror, like the first time. Now I have Brain Fog again. Who knows how long it will hang on.
Covid19SupportGrpSA retweeted
FYI, "An individual with cancer in France has become the first person known to contract the Shamonda virus..
The man, aged in his sixties, died on 9 October, 16 days after he started showing neurological symptoms, including vision loss and confusion..
He was probably infected after being bitten by midges..
There are no vaccines or antiviral treatments for orthobunyaviruses..
More orthobunyaviruses are being detected in people..
Climate change and greater contact between wildlife, livestock and humans are some of the factors that have increased the risk of people becoming infected.
Another element is that a growing number of people are immunocompromised..
Having a suppressed immune system probably allows the virus to persist in the body, which means it has a higher chance of crossing a semi-permeable membrane called the blood–brain barrier, infecting the brain and causing fatal inflammation.
Post-mortem samples from the [French] man’s brain, liver and spleen all showed high levels of the virus."
The population of immunocompromised individuals is growing.
'First person infected with rare Shamonda virus: what we know'
nature.com/articles/d41586-0…
Covid19SupportGrpSA retweeted
This is a very interesting study from Fred Hutchinson Cancer Center. It suggests that SARS-CoV-2 may be evolving in a way that makes it increasingly difficult for the human immune system to recognize the virus in the first place—not simply harder for existing antibodies to neutralize it.
So now one has to wonder whether if fewer naïve human B cells can recognize an evolved virus, will the vaccines even work? Will they have a difficult time recruiting genuinely new B-cell specificities?
Doesn't this seem like an issue worth considering @FDADrugs @FDA @CDC @NIHDirector_Jay?
Link to paper: biorxiv.org/content/10.64898…
Covid19SupportGrpSA retweeted
Well, well, well…
For the record, the whole “Covid will evolve to become milder & more benign over time” thing was always a lie.
This raises a lot of concerning questions. I would like to once again point out we have no idea what we are doing.
This is a very interesting study from Fred Hutchinson Cancer Center. It suggests that SARS-CoV-2 may be evolving in a way that makes it increasingly difficult for the human immune system to recognize the virus in the first place—not simply harder for existing antibodies to neutralize it.
So now one has to wonder whether if fewer naïve human B cells can recognize an evolved virus, will the vaccines even work? Will they have a difficult time recruiting genuinely new B-cell specificities?
Doesn't this seem like an issue worth considering @FDADrugs @FDA @CDC @NIHDirector_Jay?
Link to paper: biorxiv.org/content/10.64898…
Covid19SupportGrpSA retweeted
Kenya has recorded a second Ebola death, the health ministry said late on Friday, adding that the 65-year-old woman had developed symptoms during quarantine and was a close relative of a Kenyan man who died of Ebola earlier this month. reuters.com/business/healthc…
































